Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders (SSAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00690352
Recruitment Status : Completed
First Posted : June 4, 2008
Last Update Posted : June 13, 2019
Sponsor:
Information provided by (Responsible Party):
Kathleen Grant MD, University of Nebraska

Tracking Information
First Submitted Date May 6, 2008
First Posted Date June 4, 2008
Last Update Posted Date June 13, 2019
Study Start Date March 2008
Actual Primary Completion Date July 6, 2008   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 30, 2014)
  • Recidivism [ Time Frame: 6 months ]
  • Recidivism [ Time Frame: 6 months ]
    The primary outcome measure was the proportion of individuals who re-offend during the six months following sentencing. Secondary outcomes measures included the percentages who violated probation during the six months following sentencing, were incarcerated for those violations, had positive drug screens and were employed at six months.
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT00690352 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders
Official Title Comparing Recidivism Rates of Felony Drug Offenders in Nebraska Who Were Sentenced to, and/or Participated in, Specialized Substance Abuse Supervision (SSAS) to Those Without SSAS
Brief Summary This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who did not participate in SSAS.
Detailed Description

Since March 2006, Specialized Substance Abuse Supervision (SSAS) has been available at five sites in Nebraska as an enhancement of probation and parole for felony drug offenders whose scores on initial screening instruments warrant such placement. SSAS enhancements to traditional probation and parole include cognitive behavioral therapy (CBT) in groups; use of incentives; positive reinforcement; and motivational interviewing.

Records of probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 were studied to assess recidivism rates. Recidivism for this study is defined as "an arrest and conviction on a new charge while on probation or parole."

The records of a matched control group of non-SSAS probationers and parolees who entered probation or parole during the same time period with similar drug felony offenses and similar screening scores were also studied. Control group was also matched, as much as possible, with similar age group, demographic data, rural/urban residence, and level of felony offense.

Investigators performed a statistical analysis to determine recidivism rates at six months post-entrance to SSAS (and for the control group, at six months post-entrance to probation or parole).

Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 at any of the five participating SSAS sites in Nebraska, plus matched sets of probationers and parolees who did not participated in SSAS at any of the probation/parole sites in the state of Nebraska.
Condition
  • Substance-related Disorders
  • Alcohol-related Disorders
Intervention Behavioral: Specialized Substance Abuse Supervision (SSAS)
Six months participation in SSAS which may include cognitive behavioral therapy (CBT) in groups; use of incentives, positive reinforcement, and/or motivational interviewing.
Other Names:
  • CBT
  • motivational interviewing
  • positive reinforcement
  • use of incentives
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: May 30, 2008)
344
Original Estimated Enrollment Same as current
Actual Study Completion Date August 20, 2008
Actual Primary Completion Date July 6, 2008   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • convicted felony drug offender
  • sentenced in Nebraska
  • probationer or parolee
  • entered probation or parole or SSAS between March 1, 2006 and February 28, 2007

Exclusion Criteria:

  • convicted felony drug offender sentenced in Nebraska starting probation or parole between March 1, 2006 and February 28, 2007 who does not match SSAS probationers/parolees in terms of age, demographics, urban v. rural residence, and/or class of felony drug offense.
Sex/Gender
Sexes Eligible for Study: All
Ages 17 Years and older   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00690352
Other Study ID Numbers 066-08-FB
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Kathleen Grant MD, University of Nebraska
Study Sponsor University of Nebraska
Collaborators Not Provided
Investigators
Principal Investigator: Kathleen M Grant, MD University of Nebraska
PRS Account University of Nebraska
Verification Date June 2019